Product Information

FT INF IBUPROFEN 50 MG/1.25 ML is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.1971 per ML under NDC 70677114601. Its NADAC has been published 107 times since Nov 6, 2024.

FDA first approved this application on Dec 16, 1998.

The High Outlier badge above means this manufacturer's average price in the Ibuprofen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

FT INF IBUPROFEN 50 MG/1.25 ML

Ibuprofen
$0.1971per ML
High Outlier
OTC

Strength

50 mg/1.25mL

NDC

70677114601

Classification

Generic

Dosage Form

SUSPENSION/ DROPS

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA075217

FDA Approved

12/16/1998

On Market Since

2/7/2024

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for FT INF IBUPROFEN 50 MG/1.25 ML has been published 107 times since Nov 6, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.1971 per ML
All-time high$0.2035 (Jun 11, 2025)
All-time low$0.1971 (Nov 18, 2026)
52-week high$0.2025
52-week low$0.1971
Median price$0.2011
Average price$0.2008
Largest weekly change-0.9% (Dec 17, 2025)
Weeks tracked107
Tracking sinceNov 6, 2024

Price History

1W

-0.3%

1M

-1.1%

3M

-1.8%

6M

-1.9%

1Y

-3.0%

3Y

N/A

5Y

N/A

All

-0.7%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FT INF IBUPROFEN 50 MG/1.25 ML?

The current National Average Drug Acquisition Cost (NADAC) for FT INF IBUPROFEN 50 MG/1.25 ML, manufactured by Strategic Sourcing Services LLC, is $0.1971 per ML (NDC 70677114601), effective Nov 18, 2026.

How has the price of FT INF IBUPROFEN 50 MG/1.25 ML changed over time?

Over the history we have for it, the NADAC for FT INF IBUPROFEN 50 MG/1.25 ML has held within roughly two percent of its current level. It has been tracked across 107 weekly CMS publications since Nov 6, 2024.

What are the highest and lowest recorded NADAC prices for FT INF IBUPROFEN 50 MG/1.25 ML?

Since Nov 6, 2024, the NADAC for FT INF IBUPROFEN 50 MG/1.25 ML has ranged from a low of $0.1971 (Nov 18, 2026) to a high of $0.2035 (Jun 11, 2025), with a median of $0.2011 per ML.

Are there cheaper alternatives to FT INF IBUPROFEN 50 MG/1.25 ML?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, INFANT IBUPROFEN 50 MG/1.25 ML, is $0.1880 per ML — about 5% below FT INF IBUPROFEN 50 MG/1.25 ML.

Who manufactures FT INF IBUPROFEN 50 MG/1.25 ML?

FT INF IBUPROFEN 50 MG/1.25 ML (NDC 70677114601) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.